{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:39:37Z","timestamp":1795041577647,"version":"4.10.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R56DK134251"],"award-info":[{"award-number":["R56DK134251"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK098079"],"award-info":[{"award-number":["R01DK098079"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41590-025-02255-y","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:01:53Z","timestamp":1756479713000},"page":"1596-1611","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5014-0039","authenticated-orcid":false,"given":"Owen P.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9679-6546","authenticated-orcid":false,"given":"Michael S.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Oetheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2210-8922","authenticated-orcid":false,"given":"Emma C.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Ping","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8339-9701","authenticated-orcid":false,"given":"Pinzhu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Costentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Salloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Reinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaeze","family":"Obinelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulandt","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1674-2557","authenticated-orcid":false,"given":"Stuti","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury V.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar D.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan I.","family":"Sadreyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7600-564X","authenticated-orcid":false,"given":"Nadia","family":"Alatrakchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2255_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77, 1335\u20131347 (2023).","journal-title":"Hepatology"},{"key":"2255_CR2","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","volume":"158","author":"RS Taylor","year":"2020","unstructured":"Taylor, R. S. et al. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterology 158, 1611\u20131625.e12 (2020).","journal-title":"Gastroenterology"},{"key":"2255_CR3","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1038\/s41591-024-02958-z","volume":"30","author":"JV Lazarus","year":"2024","unstructured":"Lazarus, J. V. et al. Opportunities and challenges following approval of resmetirom for MASH liver disease. Nat. Med. 30, 3402\u20133405 (2024).","journal-title":"Nat. Med."},{"key":"2255_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby, T. & Gautier, E. L. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat. Rev. Immunol. 22, 429\u2013443 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2255_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","volume":"185","author":"M Guilliams","year":"2022","unstructured":"Guilliams, M. et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell 185, 379\u2013396.e38 (2022).","journal-title":"Cell"},{"key":"2255_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.36","volume":"6","author":"JL Mueller","year":"2015","unstructured":"Mueller, J. L. et al. Circulating soluble CD163 is associated with steatohepatitis and advanced fibrosis in nonalcoholic fatty liver disease. Clin. Transl. Gastroenterol. 6, e114 (2015).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"2255_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/infdis\/jiy331","volume":"218","author":"A Lidofsky","year":"2018","unstructured":"Lidofsky, A. et al. Macrophage activation marker soluble CD163 is a dynamic marker of liver fibrogenesis in human immunodeficiency virus\/hepatitis C virus coinfection. J. Infect. Dis. 218, 1394\u20131403 (2018).","journal-title":"J. Infect. Dis."},{"key":"2255_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jhep.2023.02.040","volume":"80","author":"A Cui","year":"2024","unstructured":"Cui, A. et al. Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis. J. Hepatol. 80, 251\u2013267 (2024).","journal-title":"J. Hepatol."},{"key":"2255_CR9","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1002\/hep.21060","volume":"43","author":"V Racanelli","year":"2006","unstructured":"Racanelli, V. & Rehermann, B. The liver as an immunological organ. Hepatology 43, S54\u2013S62 (2006).","journal-title":"Hepatology"},{"key":"2255_CR10","doi-asserted-by":"publisher","first-page":"734229","DOI":"10.3389\/fimmu.2021.734229","volume":"12","author":"M Canton","year":"2021","unstructured":"Canton, M. et al. Reactive oxygen species in macrophages: sources and targets. Front. Immunol. 12, 734229 (2021).","journal-title":"Front. Immunol."},{"key":"2255_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri888","volume":"2","author":"MG Katze","year":"2002","unstructured":"Katze, M. G., He, Y. & Gale, M. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2, 675\u2013687 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"2255_CR12","doi-asserted-by":"publisher","first-page":"154519","DOI":"10.1016\/j.cyto.2018.08.013","volume":"124","author":"M Mohlenberg","year":"2019","unstructured":"Mohlenberg, M. et al. The role of IFN in the development of NAFLD and NASH. Cytokine 124, 154519 (2019).","journal-title":"Cytokine"},{"key":"2255_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41423-019-0278-1","volume":"17","author":"Y Lou","year":"2020","unstructured":"Lou, Y. et al. Essential roles of S100A10 in Toll-like receptor signaling and immunity to infection. Cell. Mol. Immunol. 17, 1053\u20131062 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"2255_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fcimb.2013.00052","volume":"3","author":"A Ray","year":"2013","unstructured":"Ray, A., Chakraborty, K. & Ray, P. Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation. Front. Cell. Infect. Microbiol. 3, 52 (2013).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2255_CR15","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1084\/jem.20181952","volume":"216","author":"J Mastio","year":"2019","unstructured":"Mastio, J. et al. Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs. J. Exp. Med. 216, 2150\u20132169 (2019).","journal-title":"J. Exp. Med."},{"key":"2255_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/obr.12333","volume":"17","author":"M Bekaert","year":"2016","unstructured":"Bekaert, M., Verhelst, X., Geerts, A., Lapauw, B. & Calders, P. Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review. Obes. Rev. 17, 68\u201380 (2016).","journal-title":"Obes. Rev."},{"key":"2255_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yexmp.2013.07.009","volume":"95","author":"S Krautbauer","year":"2013","unstructured":"Krautbauer, S. et al. Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Exp. Mol. Pathol. 95, 199\u2013205 (2013).","journal-title":"Exp. Mol. Pathol."},{"key":"2255_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genom. 19, 477 (2018).","journal-title":"BMC Genom."},{"key":"2255_CR19","doi-asserted-by":"publisher","first-page":"108571","DOI":"10.1016\/j.celrep.2020.108571","volume":"33","author":"T Kwak","year":"2020","unstructured":"Kwak, T. et al. Distinct populations of immune-suppressive macrophages differentiate from monocytic myeloid-derived suppressor cells in cancer. Cell Rep. 33, 108571 (2020).","journal-title":"Cell Rep."},{"key":"2255_CR20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. RNA velocity of single cells. Nature 560, 494\u2013498 (2018).","journal-title":"Nature"},{"key":"2255_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","volume":"52","author":"JS Seidman","year":"2020","unstructured":"Seidman, J. S. et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity 52, 1057\u20131074.e7 (2020).","journal-title":"Immunity"},{"key":"2255_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/jcb.24653","volume":"115","author":"CMV Barbosa","year":"2014","unstructured":"Barbosa, C. M. V., Bincoletto, C., Barros, C. C., Ferreira, A. T. & Paredes-Gamero, E. J. PLC\u03b32 and PKC are important to myeloid lineage commitment triggered by M-SCF and G-CSF. J. Cell. Biochem. 115, 42\u201351 (2014).","journal-title":"J. Cell. Biochem."},{"key":"2255_CR23","doi-asserted-by":"publisher","first-page":"e1115177","DOI":"10.1080\/2162402X.2015.1115177","volume":"5","author":"M Hollm\u00e9n","year":"2016","unstructured":"Hollm\u00e9n, M. et al. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer. Oncoimmunology 5, e1115177 (2016).","journal-title":"Oncoimmunology"},{"key":"2255_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","volume":"121","author":"S Ganguly","year":"2024","unstructured":"Ganguly, S. et al. Lipid-associated macrophages\u2019 promotion of fibrosis resolution during MASH regression requires TREM2. Proc. Natl Acad. Sci. USA 121, e2405746121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2255_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.tem.2024.04.009","volume":"35","author":"R Xu","year":"2024","unstructured":"Xu, R. et al. Lipid-associated macrophages between aggravation and alleviation of metabolic diseases. Trends Endocrinol. Metab. 35, 981\u2013995 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"2255_CR26","doi-asserted-by":"publisher","first-page":"G174","DOI":"10.1152\/ajpgi.00041.2019","volume":"318","author":"G Wei","year":"2020","unstructured":"Wei, G. et al. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 318, G174\u2013G188 (2020).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2255_CR27","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood-2009-07-235382","volume":"115","author":"B Jahrsd\u00f6rfer","year":"2010","unstructured":"Jahrsd\u00f6rfer, B. et al. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 115, 1156\u20131165 (2010).","journal-title":"Blood"},{"key":"2255_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2300343120","volume":"120","author":"L Heger","year":"2023","unstructured":"Heger, L. et al. XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors. Proc. Natl Acad. Sci. USA 120, e2300343120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2255_CR29","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/CIRCULATIONAHA.110.985523","volume":"123","author":"MM Averill","year":"2011","unstructured":"Averill, M. M. et al. S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells. Circulation 123, 1216\u20131226 (2011).","journal-title":"Circulation"},{"key":"2255_CR30","doi-asserted-by":"publisher","first-page":"eadi4191","DOI":"10.1126\/sciimmunol.adi4191","volume":"9","author":"MP Plebanek","year":"2024","unstructured":"Plebanek, M. P. et al. A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Sci. Immunol. 9, eadi4191 (2024).","journal-title":"Sci. Immunol."},{"key":"2255_CR31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42255-019-0076-1","volume":"1","author":"JT Haas","year":"2019","unstructured":"Haas, J. T. et al. Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution. Nat. Metab. 1, 604\u2013614 (2019).","journal-title":"Nat. Metab."},{"key":"2255_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.1501175","volume":"196","author":"M Rau","year":"2016","unstructured":"Rau, M. et al. Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver. J. Immunol. 196, 97\u2013105 (2016).","journal-title":"J. Immunol."},{"key":"2255_CR33","doi-asserted-by":"publisher","first-page":"e15381","DOI":"10.1172\/jci.insight.153831","volume":"8","author":"A Woestemeier","year":"2023","unstructured":"Woestemeier, A. et al. Multicytokine-producing CD4+ T cells characterize the livers of patients with NASH. JCI Insight 8, e15381 (2023).","journal-title":"JCI Insight"},{"key":"2255_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"M Dudek","year":"2021","unstructured":"Dudek, M. et al. Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. Nature 592, 444\u2013449 (2021).","journal-title":"Nature"},{"key":"2255_CR35","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister, D. et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature 592, 450\u2013456 (2021).","journal-title":"Nature"},{"key":"2255_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100473","volume":"4","author":"Y Yasumizu","year":"2024","unstructured":"Yasumizu, Y. et al. Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases. Cell Genom. 4, 100473 (2024).","journal-title":"Cell Genom."},{"key":"2255_CR37","doi-asserted-by":"publisher","first-page":"602539","DOI":"10.3389\/fimmu.2021.602539","volume":"12","author":"A Stewart","year":"2021","unstructured":"Stewart, A. et al. Single-cell transcriptomic analyses define distinct peripheral B cell subsets and discrete development pathways. Front. Immunol. 12, 602539 (2021).","journal-title":"Front. Immunol."},{"key":"2255_CR38","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1084\/jem.20030280","volume":"198","author":"M Hikida","year":"2003","unstructured":"Hikida, M., Johmura, S., Hashimoto, A., Takezaki, M. & Kurosaki, T. Coupling between B cell receptor and phospholipase C-gamma2 is essential for mature B cell development. J. Exp. Med. 198, 581\u2013589 (2003).","journal-title":"J. Exp. Med."},{"key":"2255_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183268","volume":"12","author":"A Svensson","year":"2017","unstructured":"Svensson, A., Patzi Churqui, M., Schl\u00fcter, K., Lind, L. & Eriksson, K. Maturation-dependent expression of AIM2 in human B-cells. PLoS ONE 12, e0183268 (2017).","journal-title":"PLoS ONE"},{"key":"2255_CR40","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.4049\/jimmunol.1501027","volume":"196","author":"H Li","year":"2016","unstructured":"Li, H., Borrego, F., Nagata, S. & Tolnay, M. Fc receptor-like 5 expression distinguishes two distinct subsets of human circulating tissue-like memory B cells. J. Immunol. 196, 4064\u20134074 (2016).","journal-title":"J. Immunol."},{"key":"2255_CR41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220342","volume":"220","author":"V Andreani","year":"2023","unstructured":"Andreani, V., Ramamoorthy, S., F\u00e4ssler, R. & Grosschedl, R. Integrin \u03b21 regulates marginal zone B cell differentiation and PI3K signaling. J. Exp. Med. 220, e20220342 (2023).","journal-title":"J. Exp. Med."},{"key":"2255_CR42","doi-asserted-by":"publisher","first-page":"12566","DOI":"10.3748\/wjg.v20.i35.12566","volume":"20","author":"I Maleki","year":"2014","unstructured":"Maleki, I. et al. Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. World J. Gastroenterol. 20, 12566\u201312573 (2014).","journal-title":"World J. Gastroenterol."},{"key":"2255_CR43","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.3748\/wjg.v27.i43.7563","volume":"27","author":"MA De Roza","year":"2021","unstructured":"De Roza, M. A. et al. Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study. World J. Gastroenterol. 27, 7563\u20137571 (2021).","journal-title":"World J. Gastroenterol."},{"key":"2255_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2344905","volume":"13","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity. Oncoimmunology 13, 2344905 (2024).","journal-title":"Oncoimmunology"},{"key":"2255_CR45","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3389\/fimmu.2018.02324","volume":"9","author":"R Castriconi","year":"2018","unstructured":"Castriconi, R. et al. Molecular mechanisms directing migration and retention of natural killer cells in human tissues. Front. Immunol. 9, 2324 (2018).","journal-title":"Front. Immunol."},{"key":"2255_CR46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin, S., Plikus, M. V. & Nie, Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat. Protoc. 20, 180\u2013219 (2025).","journal-title":"Nat. Protoc."},{"key":"2255_CR47","doi-asserted-by":"publisher","first-page":"105614","DOI":"10.1016\/j.jbc.2023.105614","volume":"300","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y. & Lu, L. New insight into the agonism of protease-activated receptors as an immunotherapeutic strategy. J. Biol. Chem. 300, 105614 (2024).","journal-title":"J. Biol. Chem."},{"key":"2255_CR48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","volume":"130","author":"S Radaeva","year":"2006","unstructured":"Radaeva, S. et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130, 435\u2013452 (2006).","journal-title":"Gastroenterology"},{"key":"2255_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61510-4","volume":"10","author":"T Seitz","year":"2020","unstructured":"Seitz, T. et al. Fibroblast growth factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma. Sci. Rep. 10, 4546 (2020).","journal-title":"Sci. Rep."},{"key":"2255_CR50","doi-asserted-by":"publisher","first-page":"848367","DOI":"10.3389\/fimmu.2022.848367","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou, L. et al. Integrated analysis highlights the immunosuppressive role of TREM2+ macrophages in hepatocellular carcinoma. Front. Immunol. 13, 848367 (2022).","journal-title":"Front. Immunol."},{"key":"2255_CR51","doi-asserted-by":"publisher","first-page":"e01743-19","DOI":"10.1128\/mBio.01743-19","volume":"10","author":"JN Ahmad","year":"2019","unstructured":"Ahmad, J. N. et al. Bordetella adenylate cyclase toxin inhibits monocyte-to-macrophage transition and dedifferentiates human alveolar macrophages into monocyte-like cells. mBio 10, e01743-19 (2019).","journal-title":"mBio"},{"key":"2255_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cellsig.2018.06.005","volume":"49","author":"B Wahlang","year":"2018","unstructured":"Wahlang, B., McClain, C., Barve, S. & Gobejishvili, L. Role of cAMP and phosphodiesterase signaling in liver health and disease. Cell. Signal. 49, 105\u2013115 (2018).","journal-title":"Cell. Signal."},{"key":"2255_CR53","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41591-021-01344-3","volume":"27","author":"A Deczkowska","year":"2021","unstructured":"Deczkowska, A. et al. XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. Nat. Med. 27, 1043\u20131054 (2021).","journal-title":"Nat. Med."},{"key":"2255_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05784-3","volume":"9","author":"F Wimmers","year":"2018","unstructured":"Wimmers, F. et al. Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells. Nat. Commun. 9, 3317 (2018).","journal-title":"Nat. Commun."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02255-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02255-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02255-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:05:15Z","timestamp":1793063115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02255-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2255"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02255-y","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.D.C. was formerly employed by Bristol Myers Squibb. R.T.C. received research grants to the institution from Abbvie, Gilead Sciences, Merck, Boehringer, Janssen and BMS. N.A. received a research grant to the institution from Boehringer for unrelated work. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}